Why is NeoGenomics, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -229.88% of over the last 5 years
2
Positive results in Mar 26
- OPERATING CASH FLOW(Y) Highest at USD 22.41 MM
- NET PROFIT(HY) Higher at USD -24.71 MM
- RAW MATERIAL COST(Y) Fallen by -0.39% (YoY)
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 63.62%, its profits have fallen by -8.7%
4
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Market Beating Performance
- The stock has generated a return of 63.62% in the last 1 year, much higher than market (S&P 500) returns of 22.24%
How much should you hold?
- Overall Portfolio exposure to NeoGenomics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is NeoGenomics, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
NeoGenomics, Inc.
63.62%
-0.23
60.70%
S&P 500
22.24%
1.67
13.28%
Quality key factors
Factor
Value
Sales Growth (5y)
10.35%
EBIT Growth (5y)
-229.88%
EBIT to Interest (avg)
-38.77
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.21
Sales to Capital Employed (avg)
0.48
Tax Ratio
1.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.12
EV to EBIT
-16.13
EV to EBITDA
-691.58
EV to Capital Employed
1.09
EV to Sales
1.54
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-6.78%
ROE (Latest)
-8.39%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Movement
8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 22.41 MM
NET PROFIT(HY)
Higher at USD -24.71 MM
RAW MATERIAL COST(Y)
Fallen by -0.39% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 4.66 times
-3What is not working for the Company
CASH AND EQV(HY)
Lowest at USD 305.76 MM
DEBT-EQUITY RATIO
(HY)
Highest at 31.66 %
INVENTORY TURNOVER RATIO(HY)
Lowest at 14.8 times
Here's what is working for NeoGenomics, Inc.
Operating Cash Flow
Highest at USD 22.41 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
Higher at USD -24.71 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Debtors Turnover Ratio
Highest at 4.66 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -0.39% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for NeoGenomics, Inc.
Cash and Eqv
Lowest at USD 305.76 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at 31.66 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Inventory Turnover Ratio
Lowest at 14.8 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio






